![The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist | Journal of Medicinal Chemistry The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/jm3009103/asset/images/medium/jm-2012-009103_0017.gif)
The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist | Journal of Medicinal Chemistry
![Neutrophils Protect Against Staphylococcus aureus Endocarditis Progression Independent of Extracellular Trap Release | Arteriosclerosis, Thrombosis, and Vascular Biology Neutrophils Protect Against Staphylococcus aureus Endocarditis Progression Independent of Extracellular Trap Release | Arteriosclerosis, Thrombosis, and Vascular Biology](https://www.ahajournals.org/cms/asset/e01b297c-42cb-4ba7-871f-d1e0acee10e8/atvbaha.122.317800.fig09.jpg)
Neutrophils Protect Against Staphylococcus aureus Endocarditis Progression Independent of Extracellular Trap Release | Arteriosclerosis, Thrombosis, and Vascular Biology
![Enrico Marco Heffler | Enrico Marco Heffler, University of Catania | Journal of Pulmonology and Respiratory Research | HSPI Enrico Marco Heffler | Enrico Marco Heffler, University of Catania | Journal of Pulmonology and Respiratory Research | HSPI](https://www.pulmonolrespirjournal.com/images/editorial-board/enrico-marco-heffler.jpg)